CellCarta
  • Newsletter
  • Careers
  • News
  • Contact
LinkedIn facebook
Recherche
fr CH
  • Solutions
    Testing Services
    • Biomarker Solutions
      • Clinical Biomarkers
      • MS based Biomarker Services
    • Immune Monitoring
      • Basophil Activation Test (BAT)
      • Cell Enumeration
      • Cellular Phenotyping
      • Cellular Proliferation
      • Intracellular Cytokine Staining (ICS) assays
      • Fluorescence-Activated Cell Sorting (FACS)
      • MDSC Assays
      • Receptor Occupancy (RO) Assays
    • Proteomics
      • B-cell Maturation Antigen (BCMA)
      • Biomarkers in FFPE
      • Immunoassays
      • Immuno-MRM Assays
      • PK by MS
    • Genomics
      • All Genomic Services
      • Digital PCR (dPCR)
      • Quantitative PCR
      • RNA Sequencing Services
    • Histopathology
      • All Histopathology Services
      • Digital Pathology Solutions
      • IHC-IF
      • IHC Biomarker Menu
      • ISH
      • Pathology Team
    • Data Analysis
      • Bioinformatics and Biostatistics
      • Antigen AtlasTM Database
      • CellEngine® Software
      • Genomic Data Analysis
    • Regulatory Expertise
      • Companion Diagnostic (CDx) Services
      • Quality Management Systems
      • Clinical Laboratory Services
    Technologies
    • Ella™
    • ELISA
    • ELISpot and FluoroSpot
    • Flow Cytometry
    • Olink™ PEA Technology
    • Mass Cytometry (CyTOF)
    • Mass Spectrometry
    • MSD®
    • NanostringTM
    • RareCyte
    • Single-Cell Sequencing
    • Spatial Biology
    Therapeutic Expertise
    • Antibody-drug conjugates (ADCs) solutions
    • Cell Therapy
    • Infectious Diseases
    • Immunology
    • Neurosciences
    • Oncology
    • Targeted Protein Degraders
    Lab Logistic Services
    • Biorepository Services
    • Clinical Site Training
    • Global PBMC Processing Services
    • Kitting Solutions
    • Sample Logistics
  • Science Hub
    • Brochures & Infographics
    • Case Studies & Whitepapers
    • CellTalk Blog
    • News
    • Posters
    • Scientific Publications
    • Videos
    • Webcasts & Webinars
  • Events
  • About us
Testing Services
  • Biomarker Solutions
    • Clinical Biomarkers
    • MS based Biomarker Services
  • Immune Monitoring
    • Basophil Activation Test (BAT)
    • Cell Enumeration
    • Cellular Phenotyping
    • Cellular Proliferation
    • Intracellular Cytokine Staining (ICS) assays
    • Fluorescence-Activated Cell Sorting (FACS)
    • MDSC Assays
    • Receptor Occupancy (RO) Assays
  • Proteomics
    • B-cell Maturation Antigen (BCMA)
    • Biomarkers in FFPE
    • Immunoassays
    • Immuno-MRM Assays
    • PK by MS
  • Genomics
    • All Genomic Services
    • Digital PCR (dPCR)
    • Quantitative PCR
    • RNA Sequencing Services
  • Histopathology
    • All Histopathology Services
    • Digital Pathology Solutions
    • IHC-IF
    • IHC Biomarker Menu
    • ISH
    • Pathology Team
  • Data Analysis
    • Bioinformatics and Biostatistics
    • Antigen AtlasTM Database
    • CellEngine® Software
    • Genomic Data Analysis
  • Regulatory Expertise
    • Companion Diagnostic (CDx) Services
    • Quality Management Systems
    • Clinical Laboratory Services
Technologies
  • Ella™
  • ELISA
  • ELISpot and FluoroSpot
  • Flow Cytometry
  • Olink™ PEA Technology
  • Mass Cytometry (CyTOF)
  • Mass Spectrometry
  • MSD®
  • NanostringTM
  • RareCyte
  • Single-Cell Sequencing
  • Spatial Biology
Therapeutic Expertise
  • Antibody-drug conjugates (ADCs) solutions
  • Cell Therapy
  • Infectious Diseases
  • Immunology
  • Neurosciences
  • Oncology
  • Targeted Protein Degraders
Lab Logistic Services
  • Biorepository Services
  • Clinical Site Training
  • Global PBMC Processing Services
  • Kitting Solutions
  • Sample Logistics
Close icon
Close icon

Cellular Immunity Is Critical for Assessing COVID-19 Vaccine Effectiveness in Immunocompromised Individuals

Home > Science Hub > Cellular Immunity Is Critical for Assessing COVID-19 Vaccine Effectiveness in Immunocompromised Individuals
Back to the list Next article Previous article

May 26, 2022

Eustache Paramithiotis et al. Frontiers in Immunology 2023

Cellular Immunity Is Critical for Assessing COVID-19 Vaccine Effectiveness in Immunocompromised Individuals

Cellular Immunity Is Critical for Assessing COVID-19 Vaccine Effectiveness in Immunocompromised Individuals

Email
LinkedIn
Twitter
Facebook

You might also be interested by

Posters

Comparable detection of large tumor-derived vesicles (oncosomes) by known CTC platforms: potential new analyte for biomarker monitoring?

April 27, 2025

More info

Case Studies & Whitepapers

Development of a personalized digital biomarker of vaccine-associated reactogenicity using wearable sensors and digital twin technology

April 21, 2025

More info

Brochures & Infographics

Advance Your ADC Programs with CellCarta

April 16, 2025

More info

Posters

Qualification of Gene and Protein Signatures from CITE-seq Data for Deep Immunophenotyping in Human Clinical Trials

April 7, 2025

More info
CellCarta

Services

  • Bioinformatics and Biostatistics
  • CellEngine® Software
  • CDx services
  • Digital Pathology Solutions
  • All Genomic Services
  • Histopathology Services
  • Immune Monitoring
  • Immunoassays
  • Lab Logistics Services
  • Proteomic Services

Technologies

  • Flow Cytometry
  • Olink™ PEA Technology
  • Mass Spectrometry
  • RareCyte
  • Spatial Biology

About us

  • Discover CellCarta
  • Our Science Hub
Contact us Subscribe to our newsletter
LinkedIn facebook

© 2025 CellCarta - All rights reserved.

Privacy Policy Cookie Policy